Literature DB >> 34341842

Emerging liver organoid platforms and technologies.

Do Thuy Uyen Ha Lam1,2, Yock Young Dan2,3, Yun-Shen Chan4,5, Huck-Hui Ng6,7,8,9.   

Abstract

Building human organs in a dish has been a long term goal of researchers in pursue of physiologically relevant models of human disease and for replacement of worn out and diseased organs. The liver has been an organ of interest for its central role in regulating body homeostasis as well as drug metabolism. An accurate liver replica should contain the multiple cell types found in the organ and these cells should be spatially organized to resemble tissue structures. More importantly, the in vitro model should recapitulate cellular and tissue level functions. Progress in cell culture techniques and bioengineering approaches have greatly accelerated the development of advance 3-dimensional (3D) cellular models commonly referred to as liver organoids. These 3D models described range from single to multiple cell type containing cultures with diverse applications from establishing patient-specific liver cells to modeling of chronic liver diseases and regenerative therapy. Each organoid platform is advantageous for specific applications and presents its own limitations. This review aims to provide a comprehensive summary of major liver organoid platforms and technologies developed for diverse applications.
© 2021. The Author(s).

Entities:  

Keywords:  Disease models; Liver; Organoids; Regenerative therapy; Stem cells

Year:  2021        PMID: 34341842     DOI: 10.1186/s13619-021-00089-1

Source DB:  PubMed          Journal:  Cell Regen        ISSN: 2045-9769


  79 in total

Review 1.  Biotechnology Challenges to In Vitro Maturation of Hepatic Stem Cells.

Authors:  Chen Chen; Alejandro Soto-Gutierrez; Pedro M Baptista; Bart Spee
Journal:  Gastroenterology       Date:  2018-02-08       Impact factor: 22.682

2.  Fabrication of 3D-culture platform with sandwich architecture for preserving liver-specific functions of hepatocytes using 3D bioprinter.

Authors:  Kenichi Arai; Toshiko Yoshida; Motonori Okabe; Mitsuaki Goto; Tanveer Ahmad Mir; Chika Soko; Yoshinari Tsukamoto; Toshihiro Akaike; Toshio Nikaido; Kaixuan Zhou; Makoto Nakamura
Journal:  J Biomed Mater Res A       Date:  2017-03-23       Impact factor: 4.396

3.  Organoid models of human and mouse ductal pancreatic cancer.

Authors:  Sylvia F Boj; Chang-Il Hwang; Lindsey A Baker; Iok In Christine Chio; Dannielle D Engle; Vincenzo Corbo; Myrthe Jager; Mariano Ponz-Sarvise; Hervé Tiriac; Mona S Spector; Ana Gracanin; Tobiloba Oni; Kenneth H Yu; Ruben van Boxtel; Meritxell Huch; Keith D Rivera; John P Wilson; Michael E Feigin; Daniel Öhlund; Abram Handly-Santana; Christine M Ardito-Abraham; Michael Ludwig; Ela Elyada; Brinda Alagesan; Giulia Biffi; Georgi N Yordanov; Bethany Delcuze; Brianna Creighton; Kevin Wright; Youngkyu Park; Folkert H M Morsink; I Quintus Molenaar; Inne H Borel Rinkes; Edwin Cuppen; Yuan Hao; Ying Jin; Isaac J Nijman; Christine Iacobuzio-Donahue; Steven D Leach; Darryl J Pappin; Molly Hammell; David S Klimstra; Olca Basturk; Ralph H Hruban; George Johan Offerhaus; Robert G J Vries; Hans Clevers; David A Tuveson
Journal:  Cell       Date:  2014-12-31       Impact factor: 41.582

4.  3D liver membrane system by co-culturing human hepatocytes, sinusoidal endothelial and stellate cells.

Authors:  Haysam Mohamed Magdy Ahmed; Simona Salerno; Sabrina Morelli; Lidietta Giorno; Loredana De Bartolo
Journal:  Biofabrication       Date:  2017-05-26       Impact factor: 9.954

5.  Hepatocyte-based in vitro model for assessment of drug-induced cholestasis.

Authors:  Sagnik Chatterjee; Lysiane Richert; Patrick Augustijns; Pieter Annaert
Journal:  Toxicol Appl Pharmacol       Date:  2013-11-07       Impact factor: 4.219

Review 6.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

Review 7.  Liver cell therapy: is this the end of the beginning?

Authors:  Salamah M Alwahsh; Hassan Rashidi; David C Hay
Journal:  Cell Mol Life Sci       Date:  2017-11-27       Impact factor: 9.261

8.  A human liver cell atlas reveals heterogeneity and epithelial progenitors.

Authors:  Antonio Saviano; Nadim Aizarani; Laurent Mailly; Sarah Durand; Josip S Herman; Patrick Pessaux; Thomas F Baumert; Dominic Grün
Journal:  Nature       Date:  2019-07-10       Impact factor: 49.962

9.  Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform.

Authors:  Kevin Achberger; Christopher Probst; Jasmin Haderspeck; Sylvia Bolz; Julia Rogal; Johanna Chuchuy; Marina Nikolova; Virginia Cora; Lena Antkowiak; Wadood Haq; Nian Shen; Katja Schenke-Layland; Marius Ueffing; Stefan Liebau; Peter Loskill
Journal:  Elife       Date:  2019-08-27       Impact factor: 8.140

10.  Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

Authors:  Laura Broutier; Gianmarco Mastrogiovanni; Monique Ma Verstegen; Hayley E Francies; Lena Morrill Gavarró; Charles R Bradshaw; George E Allen; Robert Arnes-Benito; Olga Sidorova; Marcia P Gaspersz; Nikitas Georgakopoulos; Bon-Kyoung Koo; Sabine Dietmann; Susan E Davies; Raaj K Praseedom; Ruby Lieshout; Jan N M IJzermans; Stephen J Wigmore; Kourosh Saeb-Parsy; Mathew J Garnett; Luc Jw van der Laan; Meritxell Huch
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

View more
  2 in total

Review 1.  Modelling metabolic diseases and drug response using stem cells and organoids.

Authors:  Wenxiang Hu; Mitchell A Lazar
Journal:  Nat Rev Endocrinol       Date:  2022-09-07       Impact factor: 47.564

Review 2.  Advancements in MAFLD Modeling with Human Cell and Organoid Models.

Authors:  Shi-Xiang Wang; Ji-Song Yan; Yun-Shen Chan
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.